These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19079325)

  • 1. Murine cardiac mtDNA: effects of transgenic manipulation of nucleoside phosphorylation.
    Kohler JJ; Hosseini SH; Cucoranu I; Hoying-Brandt A; Green E; Johnson D; Wittich B; Srivastava J; Ivey K; Fields E; Russ R; Raper CM; Santoianni R; Lewis W
    Lab Invest; 2009 Feb; 89(2):122-30. PubMed ID: 19079325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-targeted transgenic mutant mitochondrial enzymes: mtDNA defects, antiretroviral toxicity and cardiomyopathy.
    Kohler JJ; Hosseini SH; Green E; Hoying-Brandt A; Cucoranu I; Haase CP; Russ R; Srivastava J; Ivey K; Ludaway T; Kapoor V; Abuin A; Shapoval A; Santoianni R; Saada A; Elpeleg O; Lewis W
    Cardiovasc Toxicol; 2008; 8(2):57-69. PubMed ID: 18446447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted transgenic overexpression of mitochondrial thymidine kinase (TK2) alters mitochondrial DNA (mtDNA) and mitochondrial polypeptide abundance: transgenic TK2, mtDNA, and antiretrovirals.
    Hosseini SH; Kohler JJ; Haase CP; Tioleco N; Stuart T; Keebaugh E; Ludaway T; Russ R; Green E; Long R; Wang L; Eriksson S; Lewis W
    Am J Pathol; 2007 Mar; 170(3):865-74. PubMed ID: 17322372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic cardiac-targeted overexpression of human thymidylate kinase.
    Kohler JJ; Hosseini SH; Cucoranu I; Zhelyabovska O; Green E; Ivey K; Abuin A; Fields E; Hoying A; Russ R; Santoianni R; Raper CM; Yang Q; Lavie A; Lewis W
    Lab Invest; 2010 Mar; 90(3):383-90. PubMed ID: 20065942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial toxicity in hearts of CD-1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination.
    Chan SS; Santos JH; Meyer JN; Mandavilli BS; Cook DL; McCash CL; Kissling GE; Nyska A; Foley JF; van Houten B; Copeland WC; Walker VE; Witt KL; Bishop JB
    Environ Mol Mutagen; 2007; 48(3-4):190-200. PubMed ID: 16395692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse model with deficient mitochondrial polymerase exhibits reduced state IV respiration and enhanced cardiac fibrosis.
    Koczor CA; Torres RA; Fields E; Qin Q; Park J; Ludaway T; Russ R; Lewis W
    Lab Invest; 2013 Feb; 93(2):151-8. PubMed ID: 23090637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.
    Lewis W; Haase CP; Miller YK; Ferguson B; Stuart T; Ludaway T; McNaught J; Russ R; Steltzer J; Santoianni R; Long R; Fiermonte G; Palmieri F
    Lab Invest; 2005 Aug; 85(8):972-81. PubMed ID: 15951836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In utero exposure of female CD-1 mice to AZT and/or 3TC: II. Persistence of functional alterations in cardiac tissue.
    Torres SM; Divi RL; Walker DM; McCash CL; Carter MM; Campen MJ; Einem TL; Chu Y; Seilkop SK; Kang H; Poirier MC; Walker VE
    Cardiovasc Toxicol; 2010 Jun; 10(2):87-99. PubMed ID: 20155331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In utero exposure of female CD-1 Mice to AZT and/or 3TC: I. Persistence of microscopic lesions in cardiac tissue.
    Torres SM; March TH; Carter MM; McCash CL; Seilkop SK; Poirier MC; Walker DM; Walker VE
    Cardiovasc Toxicol; 2010 Mar; 10(1):37-50. PubMed ID: 20101476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of mitochondrial toxicity in hearts of transgenic mice treated with abacavir.
    Kohler JJ; Hosseini SH; Green E; Fields E; Abuin A; Ludaway T; Russ R; Lewis W
    Cardiovasc Toxicol; 2010 Jun; 10(2):146-51. PubMed ID: 20379802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic mitochondrial superoxide dismutase and mitochondrially targeted catalase prevent antiretroviral-induced oxidative stress and cardiomyopathy.
    Kohler JJ; Cucoranu I; Fields E; Green E; He S; Hoying A; Russ R; Abuin A; Johnson D; Hosseini SH; Raper CM; Lewis W
    Lab Invest; 2009 Jul; 89(7):782-90. PubMed ID: 19398959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased mtDNA, oxidative stress, cardiomyopathy, and death from transgenic cardiac targeted human mutant polymerase gamma.
    Lewis W; Day BJ; Kohler JJ; Hosseini SH; Chan SS; Green EC; Haase CP; Keebaugh ES; Long R; Ludaway T; Russ R; Steltzer J; Tioleco N; Santoianni R; Copeland WC
    Lab Invest; 2007 Apr; 87(4):326-35. PubMed ID: 17310215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse models of mitochondrial toxicity associated with HIV/AIDS and antiretrovirals.
    Koczor C; Kohler J; Lewis W
    Methods; 2010 Aug; 51(4):399-404. PubMed ID: 20045731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
    Divi RL; Einem TL; Fletcher SL; Shockley ME; Kuo MM; St Claire MC; Cook A; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
    Toxicol Sci; 2010 Nov; 118(1):191-201. PubMed ID: 20702595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of mitochondrial toxicity in hearts of female B6C3F1 mice exposed in utero to 3'-azido-3'-deoxythymidine.
    Walker DM; Poirier MC; Campen MJ; Cook DL; Divi RL; Nagashima K; Lund AK; Cossey PY; Hahn FF; Walker VE
    Cardiovasc Toxicol; 2004; 4(2):133-53. PubMed ID: 15371630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac mitochondrial compromise in 1-yr-old Erythrocebus patas monkeys perinatally-exposed to nucleoside reverse transcriptase inhibitors.
    Divi RL; Leonard SL; Kuo MM; Walker BL; Orozco CC; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Thamire C; Sable CA; Poirier MC
    Cardiovasc Toxicol; 2005; 5(3):333-46. PubMed ID: 16244378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
    Balcarek K; Venhoff N; Deveaud C; Beauvoit B; Bonnet J; Kirschner J; Venhoff AC; Lebrecht D; Walker UA
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):550-7. PubMed ID: 20827217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocebus patas monkey offspring exposed perinatally to NRTIs sustain skeletal muscle mitochondrial compromise at birth and at 1 year of age.
    Divi RL; Leonard SL; Walker BL; Kuo MM; Shockley ME; St Claire MC; Nagashima K; Harbaugh SW; Harbaugh JW; Poirier MC
    Toxicol Sci; 2007 Sep; 99(1):203-13. PubMed ID: 17545213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.